TechCrunch LA

OCTOBER 5, 2020

The funding is coming from funds and accounts managed by BlackRock, Reimagined Ventures, Trinity Capital Investment, Celtic House Venture Partners, Marubeni Ventures, Sixty Degree Capital, Mojo Partners alongside with previous investors GGV Capital, WI Harper Group, Digital Garage, CentreGold Capital , Scrum Ventures, and other unnamed participants.

Technical Review 343

Technical Review Startup Marketing San Diego 343

socalTECH

OCTOBER 16, 2014

San Diego-based marketing analytics developer Anametrix has been acquired by Silicon Valley company Ensighten , according to the companies. Financial terms of the acquisition were not disclosed. Ensighten said it will use the acquisition to accelerate the next generation of its open marketing platform.

San Diego 147

San Diego Acquisition Platform Marketing 147

socalTECH

AUGUST 16, 2021

San Diego-based sales and marketing software developer Seismic has raised $170M in a Series G funding round, the company said this morning, and is now valued at $3 billion. Financial details of that acquisition were not announced. Rowe Price, according to the company. Seismic has now raised $440M in total funding.

San Diego 113

San Diego Coach Sales Training 113

socalTECH

MAY 19, 2014

Action sports camera maker GoPro , which has a few Southern California connections, has filed for an IPO, saying Monday in a regulatory filing that it is looking to raise $100M on the NASDAQ Global Select Market as GPRO. In addition, a number of GoPro''s employees came from Cineform, which was based in San Diego. READ MORE>>.

Southern California 196

Southern California Steamboat Ventures SoCal San Diego 196

socalTECH

DECEMBER 30, 2016

Here, we have the thoughts of Jeb Spencer of TVC Capital (www.tvccapital.com), a software focused growth equity fund, and has had some great success in the market. TVC Capital has also been a big supporter and sponsor of socaltech over the years. You can see all of our holiday reflections here.

Capital 113

Capital Southern California Equity San Diego 113

socalTECH

NOVEMBER 10, 2010

One of the portfolio firms of San Diego-based venture capital firm Enterprise Partners , Complete Genomics is set to debut on the market Thursday, after pricing its IPO this evening. Complete Genomics will trade on the NASDAQ Global Market as GNOM. per share, below an earlier estimated range of $12.00

Enterprise Partners 124

Enterprise Partners Marketing San Diego Acquisition 124

socalTECH

APRIL 15, 2021

San Diego-based TuSimple priced its IPO last night, saying that it will sell 33,783,783 shares of its Class A common stock at the price of $40.00 The company will begin trading this morning on the Nasdaq Global Select Market as TSP. Piper Sandler and Valuable Capital. Composite Capital Master Fund, and Navistar.

Pricing 113

Pricing Class San Diego Capital 113

socalTECH

JANUARY 21, 2021

San Diego-based Decipher Biosciences, a provider of genomic testing for urological cancer, has filed for an IPO, saying it is looking to raise up to $100M in an offering on the Nasdaq Global Market. The company has received funing from Yonghua International, CRG Partners, Tekla Capital, and UnitedHealth Group.

San Diego 113

San Diego Marketing Capital Company 113

socalTECH

NOVEMBER 17, 2020

San Diego-based Kinnate Biopharma has filed for an IPO, saying in a filing that it is looking to raise up to $100M. The company has filed to trade on the Nasdaq Global Select Market under the symbol KNTE. The firm is backed by Foresite Capital, OrbiMed, RA Capital Management, Nextech, and Vida Ventures.

San Diego 113

San Diego Capital Marketing Develop 113

socalTECH

JULY 16, 2010

Still on tap for an IPO are Pasadena-based Green Dot , Pasadena-based Genmark Diagnostics , Westlake Village-based Inphi , San Diego-based Fallbrook Technologies , Los Angeles-based GameFly , San Diego-based Trius Therapeutics , City of Industry-based NewEgg , and Thousand Oaks-based Nexsan.

Westlake Village 145

Westlake Village Woodland Hills Thousand Oaks ReachLocal 145

socalTECH

JUNE 29, 2010

On the heels of the much heralded IPO of Silicon Valley electric car darling Tesla Motors today on the NASDAQ, investors are now looking to what other firms might benefit from the electric vehicle market--and what appears to be a growing appetite for IPOs.

Southern California 176

Southern California Rustic Canyon Marketing San Diego 176

socalTECH

JUNE 28, 2012

San Diego-based ServiceNow priced its IPO on Thursday, at $18.00 ServiceNow is venture backed by JMI Equity, Sequoia Capital, and Greylock Partners. The firm's IPO performance is being closely watched, as it is the first, technology IPO to hit the markets since the Facebook IPO debacle. READ MORE>>.

Pricing 150

Pricing Marketing San Diego Equity 150

socalTECH

JUNE 23, 2020

San Diego-based Poseida Therapeutics , which is developing cell and gene therapeutics products, recently filed for an IPO, saying it is looking to raise up to $115M in a public offering. The company has filed to trade on the Nasdaq Global Select Market as PSTX. The company is led by CEO Eric Ostertag. READ MORE>>.

San Diego 113

San Diego Capital Marketing Product 113

socalTECH

JANUARY 22, 2018

San Diego-based Pulse Electronics , a supplier of electronic components to the communications, power, military, and other industries, said over the weekend that it has acquired Austrian company Egston Holdings , a provider of magnetic and cable assembly products to the electric vehicles (EV), automotive, industrial, and power magnetics markets.

San Diego 100

San Diego Equity Acquisition Capital 100

socalTECH

JANUARY 2, 2015

Today, we have some thoughts from Jeb Spencer of TVC Capital , a private equity investment company in San Diego. 2014 was the most active year in TVC history as measured by the number of investments/acquisitions/follow-ons/exits we completed. achieved a market cap of $1 billion or more. READ MORE>>.

Capital 100

Capital Cloud Computing Southern California Equity 100

socalTECH

JUNE 12, 2020

San Diego-based Avidity Bio , a biopharmaceuticals company working on oligonucleotide-based therapies, priced its IPO last night, saying that it will offer up 14,400,000 shares of its common stock at $18.00 The company said it will begin trading on the Nasdaq Global Market today, June 12th, under the ticker symbol RNA.

Pricing 113

Pricing San Diego Capital Invest 113

socalTECH

NOVEMBER 6, 2017

According to the upcoming market IPO calendar, SendGrid is planning on its IPO on Wednesday. SendGrid is venture backed by Bain Capital Ventures, Bessemer Venture Partners, Foundry Group, and Highway 12 Ventures. SendGrid is offering up 7,700,000 shares of its common stock, and most recently estimated an IPO range of between $13.50

Westlake Village 140

Westlake Village Orange County San Diego Southern California 140

Xconomy

DECEMBER 3, 2018

The acquisition, which is expected to close by the end of March 2019, continues San Diego-based ResMed’s (NYSE: RMD ) “connected healthcare” push that began about five years ago, as Xconomy chronicled last year. [ Updated 12/3/18, 3:30 pm, with CEO comments.

San Diego 93

San Diego Acquisition Capital Help 93

socalTECH

APRIL 8, 2019

San Diego-based Guardion Health Sciencs , which is developing "condition-specific medical foods and testing technologies" for the ocular health market, has raised $5.0M The company has now started trading on the Nasdaq Capital Market as GHSI. The company has now started trading on the Nasdaq Capital Market as GHSI.

San Diego 113

San Diego Pricing Capital Marketing 113

socalTECH

DECEMBER 4, 2013

San Diego-based Imagine Communications , a venture-backed developer of video transcoding and other related, IPTV and digital video streaming hardware, has been acquired by Harris Broadcast , Harris said today. Financial terms of the acquisition were not annoucned. READ MORE>>.

San Diego 147

San Diego Acquisition Los Angeles Content 147

socalTECH

OCTOBER 25, 2013

San Diego-based Sorrento Therapeutics , a biopharmaceuticals firm focused on oncology, and therapeutic products for inflammation, metabolic, and infectious diseases, has raised $30M in a public offering, and has been listed on the NASDAQ Capital Market. srne nasdaq acquisition merger therapeutics sorrento'

San Diego 157

San Diego Acquisition Capital Marketing 157

socalTECH

MARCH 30, 2011

The firm's investor was San Diego-based TVC Capital , which invested only $4M in total in Accordent before it was acquired. It was interesting to see the acquisition of Accordent - it seems unusual to have only put in $4M in to a company in so many years, and yet you had a good exit? Jeb, thanks for the time today.

Capital 168

Capital Hermosa Beach El Segundo Invest 168

socalTECH

SEPTEMBER 3, 2014

San Diego-based biopharmaceuticals developer Viking Therapeutics has set the estimated pricing for its IPO, saying in a filing Tuesday that it expects to price its IPO at between $10.00 The company has applied to list as VKTX on the NASDAQ Global market. Roth Capital Partners, Craig-Hallum Capital Group, MLV & Co.,

San Diego 138

San Diego Pricing Research Acquisition 138

socalTECH

OCTOBER 14, 2013

San Diego-based Vital Therapies has filed for an IPO, saying in a filing late Friday that it is looking to raised $86.25M in an IPO effort on the NASDAQ Global Market. vital therapies venture capital merger acquisition nasdaq lifescience biotech liver disease' The company is looking to trade as VTL. READ MORE>>.

San Diego 157

San Diego Venture Capital Acquisition Capital 157

socalTECH

MARCH 14, 2014

San Diego-based precision medicine developer Ignyta has priced its IPO, saying last night that it is offering up 5,245,000 shares of its common stock at $9.15 Ignyta will trade on the NASDAQ Capital Market as RXDX, starting today. ignyta biotech lifescience merger acquisition cancer' The IPO will raised $48.0M

Pricing 138

Pricing San Diego Startup Acquisition 138

socalTECH

MAY 2, 2014

San Diego-based life sciences investor Domain Associates has yet another company that has filed for an IPO, after the S-1 yesterday of protein analysis tools developer Protein Simple. Protein Simple said in its IPO filing that it is looking to raise up to $86.25M as PRTN on the NASDAQ Global Select Market. READ MORE>>.

San Diego 138

San Diego Tool Venture Capital Acquisition 138

socalTECH

JANUARY 6, 2016

San Diego-based medical device maker NuVasive said late Monday that it is acquiring Aliso Viejo-based skeletal deformity treatment provider Ellipse Technologies , in a deal worth $380M in cash plus up to $30M in earn out. Ellipse provides it products for the pediatric deformity and orthopedic markets. READ MORE>>.

Technology 100

Technology San Diego Equity Acquisition 100

socalTECH

JULY 30, 2014

San Diego-based XIFIN , a developer of cloud-based software for the healthcare diagnostics market, has been acquired by private equity investor GTCR. billion GTCR Fund XI, with additional funding provided by GE Capital and CapitalSource. Financial terms of the buy were not disclosed. READ MORE>>.

Windward 138

Windward SaaS Enterprise Partners San Diego 138

socalTECH

SEPTEMBER 23, 2019

A portfolio company of San Diego-based biopharmaceuticals venture investor Versant Ventures is getting set for its IPO this week. Aprea--based in Boston and Sweden--says it has applied to list on the Nasdaq Global Select Market under the symbol APRE. Morgan, Morgan Stanley, and RBC Capital Markets. and $16.00

San Diego 113

San Diego Pricing Invest Marketing 113

socalTECH

JULY 10, 2018

San Diego-based Crinetics Pharmaceuticals , a pharmaceuticals firm focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, has set its estimated IPO range, saying in a filing that it is looking to sell 5,000,000 shares of its stock at between $15.00

San Diego 133

San Diego Capital Marketing Develop 133

socalTECH

FEBRUARY 20, 2020

The newly merged company will operate under the name Forte Biosciences, and trade on the Nasdaq Capital Market as FBRX. The merged company will focus on Forte's late-stage clinical program for treating atopic dermatitis. READ MORE>>.

Torrance 113

Torrance San Diego Capital Invest 113

socalTECH

MAY 9, 2013

San Diego-based biopharmaceuticals developer Receptos is trading flat after its initial public offering, after pricing last night at $14.00 Receptos debuted this morning as RCPT on the Nasdaq Global Market. exit rcpt biopharmaceuticals biopharma lifescience acquisition merger receptos' READ MORE>>.

San Diego 159

San Diego Pricing Venture Capital Acquisition 159

socalTECH

SEPTEMBER 2, 2014

San Diego-based Omnitracs , the developer of fleet management products and services for the transportation and logistics market, said this morning that it has agreed to acquire XRS Corporation , a fellow developer of fleet optimization software. omnitracs corporation merger acquisition fleet logistics' READ MORE>>.

Trident Capital 138

Trident Capital San Diego Acquisition Software 138

socalTECH

APRIL 5, 2013

San Diego-based biopharmaceuticals firm Receptos has filed for an IPO, saying in a filing that it is looking to raise up to $86.3M in an offering on the NASDAQ Global Market. The firm''s IPO is being underwritten by Credit Suisse, Leerink Swann, BMO Capital Markets, and Wedbush PacGrow Life Sciences. READ MORE>>.

San Diego 170

San Diego Acquisition Marketing Capital 170

socalTECH

OCTOBER 14, 2013

San Diego-based Celladon , a clinical stage biopharmaceuticals firm which is developing enzymes to address calcium regulation, has filed for an IPO. The company said it is looking to raise up to $86.25M in an offering on the NASDAQ Global Market, trading under the symbol CLDN. The company''s IPO is being underwritten by J.P.

Enterprise Partners 157

Enterprise Partners San Diego Acquisition Capital 157

socalTECH

MAY 28, 2019

San Diego-based Cibus , a developer of gene editing tools being aimed at use in plant breeding, has pulled its IPO paperwork, saying in a filing that it has decided "not to proceed with the initial public offering of its securities at this time." Cibus had set an estimated initial pricing range of $14.00 READ MORE>>.

San Diego 113

San Diego Pricing Tool Invest 113

socalTECH

MAY 2, 2013

San Diego-based Ambit Biosciences has set the estimated range for its IPO, saying in a filing today that it is expecting to offer 4,645,000 shares of its stock at between $13.00 The firm has applied to list on the NASDAQ Global Market as AMBI. The offering is being run by Citigroup, Leerink Swann, BMO Capital Markets, and Baird.

San Diego 147

San Diego Acquisition Funding Marketing 147